322 related articles for article (PubMed ID: 16598415)
1. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).
Armstrong TS; Mendoza T; Gning I; Coco C; Cohen MZ; Eriksen L; Hsu MA; Gilbert MR; Cleeland C
J Neurooncol; 2006 Oct; 80(1):27-35. PubMed ID: 16598415
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of the MDASI-BT in patients with brain metastases.
Armstrong TS; Gning I; Mendoza TR; Weinberg JS; Gilbert MR; Tortorice ML; Cleeland CS
J Pain Symptom Manage; 2009 Mar; 37(3):331-40. PubMed ID: 18676120
[TBL] [Abstract][Full Text] [Related]
4. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module.
Tanaka S; Sato I; Takahashi M; Armstrong TS; Cleeland CS; Mendoza TR; Mukasa A; Takayanagi S; Narita Y; Kamibeppu K; Saito N
Jpn J Clin Oncol; 2020 Jul; 50(7):787-793. PubMed ID: 32280995
[TBL] [Abstract][Full Text] [Related]
5. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
[TBL] [Abstract][Full Text] [Related]
6. A Cross-sectional Study on the Symptom Burden of Patients With Spinal Tumor: Validation of the Chinese Version of the M.D. Anderson Symptom Inventory-Spine Tumor Module.
Xu N; Li Z; Wei F; Liu X; Jiang L; Meng N; Jiang P; Yu M; Wu F; Dang L; Zhou H; Li Y; Liu Z
J Pain Symptom Manage; 2017 Mar; 53(3):605-613. PubMed ID: 28042067
[TBL] [Abstract][Full Text] [Related]
7. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
[TBL] [Abstract][Full Text] [Related]
8. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module.
Piil K; Whisenant M; Mendoza T; Armstrong T; Cleeland C; Nordentoft S; Williams LA; Jarden M
Neurooncol Pract; 2021 Apr; 8(2):137-147. PubMed ID: 33898047
[TBL] [Abstract][Full Text] [Related]
9. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
[TBL] [Abstract][Full Text] [Related]
10. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
[TBL] [Abstract][Full Text] [Related]
11. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
[TBL] [Abstract][Full Text] [Related]
12. Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C).
Chen RW; Yang SL; Xu ZY; Peng M; Chen MN; Wang QS; Chang J; Hu JL
J Pain Symptom Manage; 2019 Apr; 57(4):820-827. PubMed ID: 30684634
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Amharic Version of the M. D. Anderson Symptom Inventory and Assessment of Symptoms in Ethiopian Cancer Patients.
Anshabo AT; Migbaru S; Mulu A; Negusu D; Asfaw AA; Awoke D; Tigeneh W; Engidawork E
J Pain Symptom Manage; 2016 May; 51(5):947-53. PubMed ID: 26988847
[TBL] [Abstract][Full Text] [Related]
14. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
[TBL] [Abstract][Full Text] [Related]
15. Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer.
Bacorro WR; Sy Ortin TT; Suarez CG; Mendoza TR; Que JC
BMJ Support Palliat Care; 2017 Jun; 7(2):140-149. PubMed ID: 25941198
[TBL] [Abstract][Full Text] [Related]
16. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
[TBL] [Abstract][Full Text] [Related]
17. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
[TBL] [Abstract][Full Text] [Related]
18. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients.
Armstrong TS; Vera-Bolanos E; Gning I; Acquaye A; Gilbert MR; Cleeland C; Mendoza T
Cancer; 2011 Jul; 117(14):3222-8. PubMed ID: 21264841
[TBL] [Abstract][Full Text] [Related]
19. Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory.
Gning I; Trask PC; Mendoza TR; Harle MT; Gutierrez KA; Kitaka SA; Sherman SI; Cleeland CS
Oncology; 2009; 76(1):59-68. PubMed ID: 19052478
[TBL] [Abstract][Full Text] [Related]
20. Linguistic Validation of the M. D. Anderson Symptom Inventory in Persian-Speaking Iranian Cancer Patients.
Saadatpour L; Hemati S; Habibi F; Behzadi E; Hashemi-Jazi MS; Kheirabadi G; Mirbagher L; Gholamrezaei A
J Pain Symptom Manage; 2015 Sep; 50(3):387-393.e1. PubMed ID: 25980966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
